← Leaderboards
Jeff C Fairman
Juvaris Biotherapeutics, Inc.
$12,403,334
Attributed
$14,993,373
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2006–25$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,993,373 · 8
By mechanism
U01$12,361,018 · 2
R43$1,817,506 · 5
R41$814,849 · 1
Top collaborators
- Toni Darville2 shared
- Aaron P Esser-Kahn2 shared
Others in their field
Top investigators on “Immunity”
- Lawrence Corey · Fred Hutchinson Cancer Center$680,290,567
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$541,067,641
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$470,748,611
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
- Judith S. Currier · University Of California Los Angeles$334,425,492
Research focus
ImmunityInfectionImmune ResponseToxicologyImmunizationVaccinesMediatingVaccinationBaseAntigensAdjuvantDoseComplexLipidsViralCd4 Positive T LymphocytesImmuneT-LymphocyteAntibodiesPreparationImmunogenicityResponseVaccine EfficacyLiposomes
Grant awards (16)
Development of a recombinant protein vaccine for Chlamydia trachomatis$1,925,693
U01 · FY2025 · AI
Development of a recombinant protein vaccine for Chlamydia trachomatis$1,959,365
U01 · FY2024 · AI
Development of a Universal Influenza Vaccine Produced by Cell-Free Protein Synthesis$196,063
R43 · FY2016 · AI · contact PI
Adjuvant Enhanced Antiviral Immunity$1,438,772
U01 · FY2011 · AI · contact PI
Adjuvant Enhanced Antiviral Immunity$260,688
U01 · FY2011 · AI · contact PI
Adjuvant Enhanced Antiviral Immunity$1,829,840
U01 · FY2010 · AI · contact PI
Adjuvant Enhanced Antiviral Immunity$1,694,391
U01 · FY2009 · AI · contact PI
Adjuvant Enhanced Antiviral Immunity$1,586,243
U01 · FY2008 · AI · contact PI
Immune Response Modification for Treatment of Hepatocellular Carcinoma$255,467
R43 · FY2008 · CA · contact PI
Adjuvant Enhanced Antiviral Immunity$1,666,026
U01 · FY2007 · AI · contact PI
Innate Immune Stimulation as a Pathogen Countermeasure$475,027
R43 · FY2007 · AI · contact PI
Lipid/DNA/Antigen Complexes for Influenza A Viral Vaccination$367,262
R41 · FY2007 · AI · contact PI
Innate Immune Stimulation as a Pathogen Countermeasure$500,833
R43 · FY2006 · AI · contact PI
Lipid/DNA/Antigen Complexes for Influenza A Viral Vaccination$447,587
R41 · FY2006 · AI · contact PI
Cationic Lipid/DNA/Antigen Complexes for Leukemia Vaccines$225,497
R43 · FY2006 · CA · contact PI
Lipid/DNA/Antigen Complexes for Pseudomonas vaccines$164,619
R43 · FY2004 · AI